A. Thayer

发表

DOW DENIES TAKEOVER RUMOR, FIRES TWO EXECS: BUSINESS TUMULT: Dow deals with upheavals around takeover talk

A. Thayer, 2007 .

WHAT'S THAT STUFF?

A. Thayer, 2000 .

Use of Specialty Food Additives To Continue To Grow

A. Thayer, 1991 .

BIOTECH FIRMS CONSOLIDATE: Amgen-Synergen, Ciba-Chiron deals set

A. Thayer, 1994 .

Enzymes at Work

Ann Thayer, A. Thayer, 2006, Science.

CONSTRUCTING LIFE SCIENCES COMPOUNDS

A. Thayer, 2006 .

Metallocene Catalysts Initiate New Era In Polymer Synthesis

Ann Thayer, A. Thayer, 1995 .

PIPELINE PAYOFF HELPS PHARMA: Drug company FIRST-HALF RESULTS were helped by new product launches and emerging-market sales

Ann Thayer, A. Thayer, 2011 .

Pharma Moves The Old Out And New In

A. Thayer, 2014 .

CHIRAL CATALYSIS: Recent chiral chemistry advances underpin the growing importance of catalyst design to accomplish a range of asymmetric reactions

A. Thayer, 2005 .

PREPARING FOR SWINE FLU: PANDEMIC: Vaccine procurement ramps up as virus gains ground

Ann Thayer, A. Thayer, 2009 .

FINDING SOLUTIONS: Custom manufacturers take on DRUG SOLUBILITY ISSUES to help pharmaceutical firms move products through development

Ann Thayer, A. Thayer, 2010 .

Bioremediation: Innovative Technology for Cleaning Up Hazardous Waste

Ann Thayer, A. Thayer, 1991 .

E-BUSINESS for CHEMICALS: Companies begin exploring electronic opportunities

Ann Thayer, A. Thayer, 2000 .

Centering on chirality

Ann Thayer, A. Thayer, 2007 .

COVER STORY: CENTERING ON CHIRALITYChemists are finding ASYMMETRIC SYNTHESIS increasingly handy for making pharmaceutical compounds at large scale

Ann Thayer, A. Thayer, 2007 .

FOR BETTER OR WORSE: Custom chemical manufacturers face ROADBLOCKS TO PROSPERITY in a shifting landscape of suppliers and pharmaceutical customers

Ann Thayer, A. Thayer, 2007 .

RESETTING PRIORITIES: The already challenging path to an HIV VACCINE takes a hard turn after recent clinical trials

Ann Thayer, A. Thayer, 2008 .

READY FOR FIVE MORE

Ann Thayer, A. Thayer, 2010 .

TAKING OVER BIG PHARMA PLANTS

Ann Thayer, A. Thayer, 2010 .

E-BUSINESS: NEWS UPDATES FOR THE WORLD OF BUSINESS ONLINE

Ann Thayer, A. Thayer, 2002 .

GREAT EXPECTATIONS: Biopharmaceutical industry expects success from new drug therapies and a full product development pipeline

Ann Thayer, A. Thayer, 1998 .

CARBON NANOTUBES BY THE METRIC TON

Ann Thayer, A. Thayer, 2007 .

FIGHTING MALARIA: New antimalarial drugs are needed to ensure that effective and affordable treatments continue to be available and are not lost to parasite resistance

A. Thayer, 2005 .

AG BIOTECH FOOD : RISKY OR RISK FREE?

Ann Thayer, A. Thayer, 1999 .

IMPROVING PEPTIDES: Small firms develop better PEPTIDE DRUG CANDIDATES to expand this pharmaceutical class and attract big pharma partners

A. Thayer, 2011 .

ISRAEL’S TEVA WILL ACQUIRE CEPHALON

Ann Thayer, A. Thayer, 2011 .

Solid Waste Concerns Spur Plastic Recycling Efforts

Ann Thayer, A. Thayer, 1989 .

Degradable Plastics Generate Controversy in Solid Waste Issues: Concerns and questions over environmental fate and role of degradable plastics in solid waste management are fostering debate on definitions and standards of new materials and products

Ann Thayer, A. Thayer, 1990 .

Technology-Based Firms Define New Business Approach To Drug Development: New generation of small companies uses biological and chemical technologies to direct, speed discovery of small-molecule drugs

A. Thayer, 1995 .

Internal Biotechnology Units Offer Growth for Pharmaceutical Firms: ▪ Changes in health care, competition from smaller companies are motivating drug firms to add new operations

Ann Thayer, A. Thayer, 1993 .

UNIVERSITIES JOIN IN ECONOMIC GROWTH: Major research universities try taking a lead role in developing local and state economies

Ann Thayer, A. Thayer, 1997 .

Sequence Of Events

Ann Thayer, A. Thayer, 2015 .

Advanced Polymer Composites Tailored for Aerospace Use

Ann Thayer, A. Thayer, 1990 .

COMPETITORS WANT TO GET A PIECE OF LIPITOR: Biocatalysis offers a variety of enantioselective routes to key chiral intermediates for the drug

Ann Thayer, A. Thayer, 2006 .

MARKET, INVESTOR ATTITUDES CHALLENGE DEVELOPERS OF BIOPHARMACEUTICALS

A. M. Thayer, A. Thayer, 1996 .

SUSTAINABLE SYNTHESES: Developing GREENER PROCESSES brings many benefits for pharmaceutical and fine chemicals manufacturers

Ann Thayer, A. Thayer, 2009 .

CUSTOM CHEMICALS: Contract manufacturers look for WAYS TO COPE with economic challenges and changes at pharmaceutical customers

Ann Thayer, A. Thayer, 2009 .

BIOCATALYSIS: Chemical and pharmaceutical makers seek more efficient and often cleaner routes to making old and new products

Ann Thayer, A. Thayer, 2001 .

The New Copycats

A. Thayer, 2014 .

FORM AND FUNCTION

Ann Thayer, A. Thayer, 2007 .

NANOTECH INVESTING: Although a few firms using nanotechnology have gone public, venture capitalists still wait for a payoff from their investments

Ann Thayer, A. Thayer, 2005 .

Grace continues buying and selling businesses

A. Thayer, 1992 .

PHENOL BACKLASH: Producers are enjoying good profits and demand, but face a potential glut from planned U.S. capacity increases

A. Thayer, 1998 .

Catalyst Suppliers Face Changing Industry

Ann Thayer, A. Thayer, 1992 .

MAKING PEPTIDES AT LARGE SCALE: EFFICIENT SYNTHESIS is helping to renew interest in the peptide drug market

Ann M. Thayer, A. Thayer, 2011 .

HARNESSING MICROREACTIONS: Researchers find that processes run in microreactors open doors to more efficient and novel chemistry useful for fine chemicals and intermediates

Ann M. Thayer, Ann M. Thayer, A. Thayer, 2005 .

Building up nanotech research

Ann Thayer, A. Thayer, 2007 .

Plastics Recycling Efforts Spurred by Concerns About Solid Waste

A. Thayer, 1990 .

GENOMICS MOVES ON

Ann Thayer, A. Thayer, 2002 .

2001 CHEMICAL INDUSTRY REVIEW: Weak economy, terrorist attacks make 2001 one of the worst years for chemical industry

Ann Thayer, A. Thayer, 2001 .

Dow, Sikorsky join in composites venture

Ann Thayer, A. Thayer, 1989 .

PLATINUM DRUGS TAKE THEIR TOLL

Ann Thayer, A. Thayer, 2010 .

Challenges Of A Biobased Economy

Ann Thayer, A. Thayer, 2000 .

Dolly's Maker To Close Its Doors

A. Thayer, 2003 .

DRUG APPROVAL: New class of cancer drugs emerges as FDA takes action on more products

Ann Thayer, A. Thayer, 2003 .

BIOPHARMACEUTICAL EARNINGS WEAKEN

Ann Thayer, A. Thayer, 2003 .

Chemical Industry Group Introduces New System for Quality Management: ▪ To aid companies in implementing quality principles, CMA offers criteria by which to assess improvements

Ann Thayer, A. Thayer, 1992 .